Clin2
NCT07320456Possibly a fitNot yet recruiting

Herbal medicine for fatty liver disease

Hepatic Steatosis

Part of Digestive system clinical trials.

This trial tests a traditional Chinese herbal mixture called 'Longqi Jiangzhi Decoction' for people with non-alcoholic fatty liver disease. It aims to see if the herbs can improve liver health and reduce fat in the liver, possibly offering a gentler treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are between 18 and 50 years old.
  • You have been diagnosed with non-alcoholic fatty liver disease (NAFLD) — fat buildup in the liver not caused by alcohol.
  • Your condition fits a traditional Chinese medicine pattern called 'spleen deficiency with damp-heat'.
  • Your liver fat measurement (CAP) is 238 or higher, and your BMI is 23 or above.
  • You have not taken any NAFLD medication in the past month, and you have not joined another trial in the last three months.
  • You are not pregnant, breastfeeding, or (if of childbearing age) you agree to use effective birth control during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06891365Recruiting· Phase 1
Multiple doses of a new drug for fatty liver disease

This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.

Harrow
NCT06739486Not yet recruiting
Testing a diabetes medicine for fatty liver disease

This study tests a medicine commonly used for diabetes to see if it can help people with fatty liver disease. The medicine may reduce fat in the liver and improve liver health.

NCT07637006Not yet recruiting· Phase 2
Herbal capsule for fatty liver with metabolic issues

This trial tests a traditional Chinese herbal capsule called Linzhi Jianghuang Fufang Huoxue Anshen. It aims to see if it can reduce fat in the liver and improve health in people with non-alcoholic fatty liver disease who also have conditions like high blood sugar, blood pressure, or cholesterol.

NCT07663643Not yet recruiting· Phase 4
Fuzheng Huayu tablets for fatty liver cirrhosis

This study tests whether a traditional Chinese medicine, Fuzheng Huayu tablets, can help people with cirrhosis caused by fatty liver disease. It aims to see if the treatment is safe and effective in stopping or slowing the disease's progression.

NCT06798948Recruiting· Phase 2
Can a mix of herbs improve mild fatty liver?

This study is testing if a combination of four herbs (artichoke, milk thistle, turmeric, and licorice root) can help people with non-alcoholic mild to moderate fatty liver disease (also called metabolic-associated fatty liver disease). It's a randomized trial, meaning participants are assigned to either the herbal mix or a comparison group. This may offer a natural option to support liver health.

Hangzhou, Select...
NCT06848907Not yet recruiting· Phase 2
A herbal capsule for fatty liver disease

This study tests a Chinese herbal capsule called Ganzhixiao for people with fatty liver disease (also called MAFLD). It aims to see if the capsule can help improve liver health and reduce fat build-up, and you'll have regular check-ups including MRI scans.

Hear when a new Hepatic Steatosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.